---

Imagine controlling a drone with just your thoughts—no joystick, no keyboard. Now picture tiny particles, smaller than a speck of dust, injected into your body to make that possible by linking your brain to machines. This is the cutting-edge reality of DARPA’s Next-Generation Nonsurgical Neurotechnology (N3) program, which concluded in 2022. Its boldest innovation? Injectable nanoparticles that enable mind-machine connections without surgery. But with such futuristic tech comes a critical question: Are these nanoparticles dangerously tampering with our brains? In this deep dive, we explore the who, what, when, where, why, and how of DARPA’s nanoparticles, weighing their potential against serious safety concerns.

What Are Injectable Nanoparticles?

Injectable nanoparticles are microscopic particles, so small thousands could fit across a human hair. In N3, they’re magnetoelectric nanoparticles (MENPs), made from materials like iron oxide, which convert magnetic fields into electric signals and vice versa. Injected into the bloodstream, these particles cross the blood-brain barrier to interact with neurons, powering a brain-machine interface (BMI). They read brain signals (e.g., “fly drone left”) and write feedback (e.g., a drone’s camera view) back to the brain—all without invasive surgery.

Unlike surgical BMIs, these nanoparticles are minutely invasive, entering via injection but designed to be temporary, magnetically removed after use. This reduces risk compared to brain implants, but injecting particles into the brain still sounds risky, raising valid safety concerns for applications like drone control or medical treatments.

Who Developed This Technology?

The Battelle Memorial Institute, a leading research organization in Columbus, Ohio, spearheaded N3’s BrainSTORMS project (Brain System to Transmit Or Receive Magnetoelectric Signals). Led by researchers like Gaurav Sharma and Patrick Ganzer, Battelle collaborated with experts from Cellular Nanomed Inc., the University of Miami, Carnegie Mellon University, and others. DARPA, the Pentagon’s innovation arm, funded the project under program manager Al Emondi, with ethical advisors ensuring responsible development. Their goal was to create safe, nonsurgical BMIs for soldiers and medical patients, pushing the boundaries of human-machine interaction Battelle Press Release.

check out our Battelle Memorial Institute article here

When Was This Developed?

DARPA launched N3 in 2018, awarding Battelle $2 million for Phase I. By 2019, lab tests (likely on animals) confirmed nanoparticles could interact with neural signals. In December 2020, Battelle advanced to Phase II, refining the tech for human use, with Phase III (2021–2022) likely involving human trials Battelle Press Release. As of May 2025, no commercial products exist, indicating the tech remains experimental, with safety studies ongoing, possibly classified for military applications like drone control.

Where Is This Happening?

Development centers at Battelle’s Ohio labs, with testing at partner institutions like the University of Miami or DARPA-affiliated facilities. Preclinical trials occurred in controlled lab settings, while human trials—potentially with military volunteers—likely took place in secure sites. Medical applications would require FDA-approved clinical testing, but military uses (e.g., drone control) may remain behind closed doors, limiting public insight DARPA N3 Program.

Why Use Nanoparticles?

Traditional BMIs involve risky brain surgery, making them impractical for healthy soldiers or widespread medical use. Nanoparticles offer a less invasive alternative, enabling precise brain communication without scalpels. N3 aimed to:

• Enable Drone Control: Allow soldiers to pilot drones or robots with thoughts, enhancing battlefield efficiency.
• Treat Neurological Disorders: Stimulate neurons to manage epilepsy, depression, or Parkinson’s, offering new hope.
• Ensure Temporariness: Magnetically remove particles post-use, avoiding permanent implants.

The vision? Soldiers commanding drones mentally or patients easing seizures without surgery. But the safety risks of injecting brain-interacting particles can’t be ignored Institute for Biodefense Research.

How Do Nanoparticles Work?

Nanoparticles act as brain-machine translators. After injection, magnetic fields guide them to targeted brain regions (e.g., motor cortex for drone commands). The process:

• Reading: Neurons fire electric signals when you think “turn drone right.” Nanoparticles convert these to magnetic signals, sent to a helmet-based transceiver. Algorithms decode them into commands.
• Writing: The drone’s camera feed is encoded as magnetic signals, relayed to nanoparticles, which stimulate neurons to “show” the image in your visual cortex.
• Removal: Magnets guide particles out via the bloodstream, ensuring they don’t linger.

They’re fast (under 50 milliseconds) and precise (sub-millimeter brain zones), ideal for real-time drone control. But their brain interaction raises serious safety questions Magnetics Magazine.

Are Nanoparticles Dangerous?

Injecting nanoparticles into the brain is, indeed, “kinda dangerous.” Here’s why:

• Toxicity Risks: If not biocompatible, particles could cause inflammation or cell damage. Iron oxide is used in MRI scans, but brain exposure is less studied.
• Neural Errors: Stimulating the wrong neurons might trigger seizures, mood swings, or cognitive issues, potentially disrupting drone control missions.
• Incomplete Removal: If particles remain, they could accumulate, leading to chronic inflammation or neurological damage.
• Long-Term Unknowns: Repeated injections (e.g., for multiple drone operations) may have unstudied effects, with no long-term human data as of 2025.
• Ethical Concerns: Reading and writing brain signals could raise privacy issues, though N3 focuses on controlled applications.

To counter these risks, Battelle uses biocompatible materials, conducts rigorous testing (lab, animals, humans), and ensures magnetic removal. Ethical oversight and informed consent for trials add safeguards. However, with no public human trial data, safety remains uncertain, especially for military uses where performance may outweigh caution Institute for Biodefense Research.

The Future of Nanoparticles

DARPA’s nanoparticles could redefine human-machine collaboration, from thought-controlled drones to breakthrough treatments for brain disorders. Their nonsurgical approach is a leap forward, but toxicity, neural risks, and lack of long-term data cast a shadow. Without transparent safety studies, we’re left wondering: Is this tech a game-changer or a risky experiment? As N3’s research shapes the future, the balance between innovation and caution remains critical.

What’s your take—revolutionary potential or dangerous gamble? Share your thoughts at AshesOnAir.org, where we probe the frontiers of science and skepticism.

Sources:

• Battelle Press Release on BrainSTORMS Phase II
• DARPA N3 Program Page
• Institute for Biodefense Research on N3 Ethics
• Magnetics Magazine on N3 Research